Abstract
Introduction and hypothesis
To evaluate clinical outcomes at 3 years following total transvaginal mesh (TVM) technique to treat vaginal prolapse.
Methods
Prospective, observational study in patients with prolapse ≥stage II. Success was defined as POP-Q-stage 0-I and absence of surgical re-intervention for prolapse. Secondary outcome measures were: quality of life (QOL), prolapse-specific inventory (PSI), impact on sexual activity and complications.
Results
Ninety women underwent TVM repair, 72 a hysterectomy. Anatomical failure rate was 20.0% at 3 years. Three patients required re-intervention for prolapse. Improvements in QOL- and PSI-scores were observed at 1 and 3 years. Vaginal mesh extrusion occurred in 14.4% patients. After 3 years, 4.7% asymptomatic extrusions remained present. Of 61 sexually active women at baseline, a significant number of patients (41%) ceased sexual activity by 3 years; de novo dyspareunia was reported by 8.8%. One vesico-vaginal fistula resolved after surgery.
Conclusion
Medium-term results demonstrate that the TVM technique provides a durable prolapse repair.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00192-010-1223-0/MediaObjects/192_2010_1223_Fig1_HTML.gif)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00192-010-1223-0/MediaObjects/192_2010_1223_Fig2_HTML.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00192-010-1223-0/MediaObjects/192_2010_1223_Fig3_HTML.gif)
Similar content being viewed by others
![](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs00192-024-05832-1/MediaObjects/192_2024_5832_Fig1_HTML.png)
Abbreviations
- BMI:
-
Body mass index
- ICS:
-
International Continence Society
- LOCF:
-
Last observation carried forward
- POP:
-
Pelvic organ prolapse
- POP-Q:
-
Pelvic organ prolapse quantification
- PSI:
-
Prolapse-specific inventory
- QOL:
-
Quality of life
- SD:
-
Standard deviation
- TVM:
-
Trans vaginal mesh
References
Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS (2001) Cost of Pelvic Organ Prolapse Surgery in the United States. Obstet Gynecol 98(4):646–651
Chen Y, DeSautel M, Anderson A, Badlani G, Kushner L (2004) Collagen synthesis is not altered in women with stress urinary incontinence. Neurourol Urodyn 23(4):367–373
Reisenauer C, Shiozawa T, Oppitz M, Busch C, Kirschniak A, Fehm T, Drews U (2008) The role of smooth muscle in the pathogenesis of pelvic organ prolapse - an immunohistochemical and morphometric analysis of the cervical third of the uterosacral ligament. Int Urogynecol J Pelvic Floor Dysfunct 19(3):383–389
Boreham MK, Wai CY, Miller RT, Schaffer JI, Word RA (2002) Morphometric analysis of smooth muscle in the anterior vaginal wall of women with pelvic organ prolapse. Am J Obstet Gynecol 187(1):56–63
Olsen A, Smith V, Bergstrom JO, Colling JC, Clark AL (1997) Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol 89:501–506
Denman MA, Gregory WT, Boyles SH, Smith V, Edwards SR, Clark AL (2008) Reoperation 10 years after surgically managed pelvic organ prolapse and urinary incontinence. Am J Obstet Gynecol 198(5):555.e1–555.e5
Julian M (1996) The efficacy of Marlex mesh in the repair of severe, recurrent vaginal prolapse of the anterior midvaginal wall. Am J Obstet Gynecol 175:1472–1475
Sand PK, Koduri S, Lobel RW, Winkler HA, Tomezsko J, Culligan PJ (2001) Prospective randomised trial of polyglactin 910 mesh to prevent recurrences of cystoceles and rectoceles. Am J Obstet Gynecol 184:1357–1364
Ulmsten U, Henriksson L, Johnson P, Varhos G (1996) An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 7:81–85
Delorme E (2001) Transobturator Sling: a minimally invasive procedure to treat female stress incontinence. Prog Urol 11:1306–1313
de Leval J (2003) Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. J Eur Urol 44:724–730
Debodinance P, Berrocal J, Clavé H, Cosson M, Garbin O, Jacquetin B, Rosenthal C, Salet-Lizée D, Villet R (2004) Changing attitudes on the surgical treatment of urogenital prolapse: birth of the tension-free vaginal mesh. J Gynecol Obstet Biol Reprod 33:577–588
Fatton B, Amblard J, Debodinance P, Cosson M, Jacquetin B (2007) Transvaginal repair of genital prolapse: preliminary results of a new tension-free vaginal mesh (Prolift™ technique)—a case series multicentric study. Int Urogynecol J 18:743–752
Nguyen JN, Burchette RJ (2008) Outcome after anterior vaginal prolapse repair: a randomized controlled trial. Obstet Gynecol 111(4):891–898
Elmér C, Altman D, Engh ME, Axelsen S, Väyrynen T, Falconer C, for the Nordic Transvaginal Mesh Group (2009) Trocar-guided transvaginal mesh repair of pelvic organ prolapse. Obstet Gynecol 113(1):117–126
Nieminen K, Hiltunen R, Heiskanen E, Takala T, Niemi K, Merikari M, Heinonen PK (2008) Symptom resolution and sexual function after anterior vaginal wall repair with or without polypropylene mesh. Int Urogynecol J Pelvic Floor Dysfunct 19(12):1611–1616
Withagen M, Milani A, Den Boon J, Vervest H, Vierhout M (2009) Tension free vaginal mesh compared to conventional vaginal prolapse surgery in recurrent prolapse: a randomized controlled trial. Int Urogynecol J Pelvic Floor Dysfunct 20(Suppl):S153
Bump RC, Mattiasson A, Bø K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175(1):10–17
Kobashi KC, Gormley EA, Govier F, Hadley R, Luber K, Nitti V (2000) Development of a validated quality of life measurement for patients with pelvic prolapse. Proceedings of the American Urological Association 95th Annual Meeting. J Urol 163:76
Benson JT, Lucente V, McClellan E (1996) Vaginal versus abdominal reconstructive surgery for the treatment of pelvic support defects: A prospective randomized study with long-term outcome evaluation. Am J Obstet Gynecol 175:1418–1422
Sze EH, Kohli N, Miklos JR, Roat T, Karram MM (1999) A retrospective comparison of abdominal sacrocolpopexy with Burch colposuspension versus sacrospinous fixation with transvaginal needle suspension for the management of vault prolapse and coexisting stress incontinence. Int Urogynecol J 10(6):390–393
Maher CF, Qatawneh AM, Dwyer PL, Carey MP, Cornish A, Schluter PJ (2004) Abdominal sacral colpopexy or vaginal sacrospinous colpopexy for vaginal wall prolapse: a prospective randomized study. Am J Obstet Gynecol 190:20–26
Diwadkar GB, Barber MD, Feiner B, Maher C, Jelovsek JE (2009) Complication and reoperation rates after apical vaginal prolapse surgical repair: a systematic review. Obstet Gynecol 113(2 Pt 1):367–373
Digesu GA, Chaliah C, Salvatore S, Hutchings A, Khullar V (2005) The relationship of vaginal prolapse severity to symptoms and quality of life. BJOG 112:971–976
Gutman R, Ford D, Quiroz L, Shippey S, Handa V (2008) Is there a pelvic organ prolapse threshold that predicts pelvic floor symptoms? Am J Obstet Gynecol 199:683.e1–683.e7
Swift SE, Tate SB, Nicholas J (2003) Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol 189:372–379
Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, Spino C (2009) Pelvic Floor Disorders Network. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol 114(3):600–609
Collinet P, Belot F, Debodinance P, Ha Duc E, Lucot JP, Cosson M (2006) Transvaginal mesh technique for pelvic organ prolapse repair: mesh exposure management and risk factors. Int Urogynecol J 17:315–320
Lowman JK, Jones LA, Woodman PJ, Hale DS (2008) Does the Prolift system cause dyspareunia? Am J Obstet Gynecol 199(6):707.e1–707.e6
Altman D, Elmér C, Kiilholma P, Kinne I, Tegerstedt G, Falconer C, Nordic Transvaginal Mesh Group (2009) Sexual dysfunction after trocar-guided transvaginal mesh repair of pelvic organ prolapse. Obstet Gynecol 113(1):127–133
Conflicts of interest
Bernard Jacquetin holds the patent for Prolift®, for which he receives royalties from Ethicon. B.Jacquetin, B. Fatton, C. Rosenthal, H. Clavé, P. Debodinance, O. Garbin, J. Berrocal, R. Villet, D. Salet Lizée and M. Cosson all have had consultancy positions for Ethicon. P. Hinoul and J. Gauld are employed by Ethicon.
Source of financial support
ETHICON Women’s Health & Urology.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jacquetin, B., Fatton, B., Rosenthal, C. et al. Total transvaginal mesh (TVM) technique for treatment of pelvic organ prolapse: a 3-year prospective follow-up study. Int Urogynecol J 21, 1455–1462 (2010). https://doi.org/10.1007/s00192-010-1223-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00192-010-1223-0